Disposition of 555 shares by Sievers Eric of Bioatla at 3.37 subject to Rule 16b-3

BCAB Stock  USD 0.47  0.01  2.17%   
About 59% of Bioatla's investor base is looking to short. The analysis of the overall investor sentiment regarding Bioatla suggests that many traders are alarmed. The current market sentiment, together with Bioatla's historical and current headlines, can help investors time the market. In addition, many technical investors use Bioatla stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Bioatla Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 555 common stock at 3.37 of Bioatla by Sievers Eric on 11th of July 2024. This event was filed by Bioatla with SEC on 2023-04-30. Statement of changes in beneficial ownership - SEC Form 4

Bioatla Fundamental Analysis

We analyze Bioatla's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioatla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioatla based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Bioatla is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Bioatla Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioatla stock to make a market-neutral strategy. Peer analysis of Bioatla could also be used in its relative valuation, which is a method of valuing Bioatla by comparing valuation metrics with similar companies.

Peers

Bioatla Related Equities

ACRVAcrivon Therapeutics,   4.84   
0%
67.0%
GLUEMonte Rosa   3.26   
0%
45.0%
ADAGAdagene   2.70   
0%
37.0%
AVTEAerovate Therapeutics   1.55   
0%
21.0%
RZLTRezolute   0.77   
0%
10.0%
ERASErasca   0.53   
0%
7.0%
IKNAIkena Oncology   0.67   
9.0%
0%
PMVPPmv Pharmaceuticals   1.39   
19.0%
0%
NRIXNurix Therapeutics   1.55   
21.0%
0%
KYMRKymera Therapeutics   2.13   
29.0%
0%
DSGNDesign Therapeutics   2.41   
33.0%
0%
ANTXAN2 Therapeutics   2.56   
35.0%
0%
NAUTNautilus Biotechnology   3.39   
47.0%
0%
FHTXFoghorn Therapeutics   3.46   
48.0%
0%
OLMAOlema Pharmaceuticals   3.48   
48.0%
0%
IPSCCentury Therapeutics   3.53   
49.0%
0%
PASGPassage Bio   4.92   
68.0%
0%
CCCCC4 Therapeutics   5.71   
79.0%
0%
STTKShattuck Labs   7.20   
100.0%
0%

Complementary Tools for Bioatla Stock analysis

When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world